Andrew D. Ashe
CIK 1573163 · See Remarks · last filed 2025-07-28
Andrew D. Ashe is a corporate insider who has filed 22 SEC Form 4 insider transactions across 3 companies since 2013. The most recent filing, for VERV, was dated Jul 28, 2025. Across all open-market trades the lifetime net is −$1.4M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
22
-$1.44M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Verve Therapeutics, Inc. (VERV) Delisted | See Remarks | 0 | $11.13 | $0 | $593.1K | 10 | 2025-07-28 |
| APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted | General Counsel | — | $0.39 | — | $0 | 1 | 2017-08-03 |
| DYAX CORP (DYAX) Delisted | General Counsel & EVP | 0 | — | — | -$2.04M | 11 | 2016-01-22 |
Recent Filings
22 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-07-28 | Verve Therapeutics, Inc. (VERV) Delisted | Mixed | −348,828 | $0 | EDGAR |
| 2025-04-03 | Verve Therapeutics, Inc. (VERV) Delisted | Mixed | +6,319 | -$11.1K | EDGAR |
| 2025-01-10 | Verve Therapeutics, Inc. (VERV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-05-15 | Verve Therapeutics, Inc. (VERV) Delisted | Buy (P) | +76,000 | $475.8K | EDGAR |
| 2024-02-16 | Verve Therapeutics, Inc. (VERV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-02-16 | Verve Therapeutics, Inc. (VERV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-08-29 | Verve Therapeutics, Inc. (VERV) Delisted | Exer (M) | +95,787 | $152.2K | EDGAR |
| 2022-02-15 | Verve Therapeutics, Inc. (VERV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-06 | Verve Therapeutics, Inc. (VERV) Delisted | Buy (P) | +4,000 | $128.4K | EDGAR |
| 2021-06-21 | Verve Therapeutics, Inc. (VERV) Delisted | Grant (A) | — | $0 | EDGAR |